Home › NCT07467720

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

Who can join

All ages · All sexes

Inclusion Criteria:

* Member of the interventional care team
* Elective peripheral procedure
* The access site is the femoral artery
* The treatment area is at or distal to the iliac artery

Exclusion Criteria:

* Individuals who are not yet adults, pregnant women, or prisoners.
* Urgent and emergent cases

About the study

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

What is being tested

• Rampart IC System (device)

Sponsor: Baylor Research Institute · Participants: 75 · Started: Aug 20, 2026

Contact the study team

• Bonnie Ostergren · Phone: 469-814-4181

Official record on ClinicalTrials.gov — NCT07467720

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.